Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gurusingham Sitta Sittampalam

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Antioxidants & Redox Signaling|May 10, 2017
Twenty-First Century Diseases: Commonly Rare and Rarely Common?Sylvia Daunert, Gurusingham Sitta Sittampalam, Pascal J Goldschmidt-Clermont
Drug Discovery Today|August 3, 2018
Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipelineJens M Kelm, Madhu Lal-Nag, Gurusingham Sitta Sittampalam, et al.
Frontiers in Robotics and AI|January 27, 2021
A Perspective on Innovating the Chemistry Lab BenchAlexander G Godfrey, Samuel G Michael, Gurusingham Sitta Sittampalam, et al.
Assay and Drug Development Technologies|July 29, 2010
Activity of anticancer agents in a three-dimensional cell culture modelVictor Sanjit Nirmalanandhan, Alicia Duren, Peter Hendricks, et al.
Frontiers in Oncology|October 30, 2014
A multicenter pilot study examining the role of circulating tumor cells as a blood-based tumor marker in patients with extensive small-cell lung cancerChao H Huang, Jo A Wick, Gurusingham Sitta Sittampalam, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Antioxidants & Redox Signaling|May 10, 2017
Twenty-First Century Diseases: Commonly Rare and Rarely Common?Sylvia Daunert, Gurusingham Sitta Sittampalam, Pascal J Goldschmidt-Clermont
Drug Discovery Today|August 3, 2018
Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipelineJens M Kelm, Madhu Lal-Nag, Gurusingham Sitta Sittampalam, et al.
Frontiers in Robotics and AI|January 27, 2021
A Perspective on Innovating the Chemistry Lab BenchAlexander G Godfrey, Samuel G Michael, Gurusingham Sitta Sittampalam, et al.
Assay and Drug Development Technologies|July 29, 2010
Activity of anticancer agents in a three-dimensional cell culture modelVictor Sanjit Nirmalanandhan, Alicia Duren, Peter Hendricks, et al.
Frontiers in Oncology|October 30, 2014
A multicenter pilot study examining the role of circulating tumor cells as a blood-based tumor marker in patients with extensive small-cell lung cancerChao H Huang, Jo A Wick, Gurusingham Sitta Sittampalam, et al.
Pageof 1